Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DDK1I4
|
|||
| Drug Name |
AT-GAA
|
|||
| Drug Type |
Protein/peptide
|
|||
| Indication | Pompe disease [ICD-11: 5C51.3; ICD-10: E74.0] | Phase 3 | [1] | |
| Company |
Amicus Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03729362) PROPEL Study - A Study Comparing ATB200/AT2221 With Alglucosidase/Placebo in Adult Subjects With LOPD. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.